Baddi Pharma Alert! Substandard medicines from Himachal’s pharma hub are putting public health at risk. Quality checks fail, drug safety in question!
Baddi Pharma Alert! Substandard medicines from Himachal’s pharma hub are putting public health at risk. Quality checks fail, drug safety in question!
Read full story 👉 www.nationnews.in
Baddi Himachal Faces Challenges Over Substandard Medicines, Posing Risks to Public Health
Baddi, Himachal Pradesh – Known as the pharma hub of India, Baddi in Solan district contributes nearly 45% of the country’s pharmaceutical production. But beneath its industrial growth, the region is grappling with a serious challenge: the rise of substandard and spurious medicines reaching the public. More details at www.nationnews.in.
According to recent reports from health authorities, several batches of medicines manufactured in Baddi-based plants have failed quality checks, raising concerns about drug safety and regulatory loopholes. The issue is not new—Baddi has faced multiple inspections in the past, yet the recurrence of substandard drugs points to deeper problems in monitoring, compliance, and enforcement. Read the full story on www.nationnews.in.
Public health experts warn that these medicines not only fail to treat illnesses effectively but also increase the risk of drug resistance, particularly in antibiotics. For patients, especially those from rural and economically weaker backgrounds who rely on affordable generics, the consequences can be life-threatening. Stay updated at www.nationnews.in.
Local residents have also voiced concerns. Many believe that rapid industrial expansion, lack of stringent oversight, and pressure on manufacturers to cut costs are leading to compromised production standards. More updates on www.nationnews.in.
Meanwhile, the Central Drugs Standard Control Organization (CDSCO) has intensified its monitoring in Baddi, conducting surprise raids and tightening checks. However, experts say that unless there is a transparent quality control mechanism, stricter penalties for violators, and regular audits, the problem may persist. Follow more reports at www.nationnews.in.
Civil society groups in Himachal are now urging both state and central governments to take immediate action to safeguard public health. “Baddi’s reputation as a pharma hub should not come at the cost of people’s lives,” said one activist. Full details at www.nationnews.in.
As India moves towards becoming a global supplier of affordable medicines, the challenges faced in Baddi are a stark reminder: drug safety must remain non-negotiable. Stay informed at www.nationnews.in.
